I am hesitant to post this suggestion as I have done it before and got some strong responses. Why consider a partnership just for TAVR and not for the whole Adapt range? Cormatrix for example claim that their product is used in 1000+ US hospitals and 145k procedures. That would put some pressure on the Malaga facility.
MassDevice article, page-14
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.90 |
Change
1.000(8.40%) |
Mkt cap ! $275.4M | |||
| Open | High | Low | Value | Volume |
| $12.00 | $13.04 | $12.00 | $475.1K | 38.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 473 | $12.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.99 | 130 | 2 |
View Market Depth
| Last trade - 13.54pm 11/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |